IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.

Saved in:
Bibliographic Details
Title: IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.
Authors: Silva BJA; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States., Krogstad PA; Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, United States., Teles RMB; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States., Andrade PR; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States., Rajfer J; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Ferrini MG; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Yang OO; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Bloom BR; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States., Modlin RL; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Dec 15; Vol. 14, pp. 1284148. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1284148